RadNet Quantib

By RadNet (formerly Quantib)
· USA (originally Netherlands)
RadNet — Breast and prostate imaging analysis.
Diagnostic
Radiology
Production
FDA Cleared
Regulatory status
FDA Cleared
Deployment
Production
Clinical role
Adjunct (decision support)
Headquarters
USA (originally Netherlands)
AI type
Diagnostic

Precise indication

Breast and prostate imaging analysis.

Regulatory status

Two recent FDA clearances confirmed (breast and prostate).

Clinical evidence

Vendor-supported

Trade press coverage of the FDA clearances.

Independent

Not found in this research pass — verify before publishing.

Real-world deployment

Integrated into RadNet’s DeepHealth suite; no independent figure found.

Interoperability

European status

Editorial verdict

Limits and uncertainties

No independent evidence found in this pass.

Sources

https://www.fiercebiotech.com/medtech/radnet-scores-two-fda-clearances-ai-programs-breast-prostate-cancer

This profile is not medical advice or an endorsement. Hospitals should perform their own due diligence (regulatory compliance, GDPR, cybersecurity, integration, local clinical validation). How we evaluate

At a glance
Vendor
RadNet (formerly Quantib)
Headquarters
USA (originally Netherlands)
AI type
Diagnostic
Specialty
Clinical role
Adjunct (decision support)
CE marking
Notified body
EU AI Act
Data hosting
Last verified
Reviewed by
How we evaluate

Every profile documents the precise indication, regulatory status, vendor-supported and independent evidence, real-world deployment, limits and dated sources.

A independent systematic review or prospective multicentre study · B at least one independent peer-reviewed study · C peer-reviewed, vendor-supported · D vendor claims only.

Read the methodology →

Spotted an error?

Vendors, authors and clinicians can request a correction. Corrections are dated on the profile.